NasdaqCM - Nasdaq Real Time Price USD

Nephros, Inc. (NEPH)

2.1550 +0.0150 (+0.70%)
As of 12:39 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
14,238.0000
14,238.0000
9,975.0000
10,217.0000
8,561.0000
Cost of Revenue
5,833.0000
5,833.0000
5,244.0000
4,584.0000
3,648.0000
Gross Profit
8,405.0000
8,405.0000
4,731.0000
5,633.0000
4,913.0000
Operating Expense
9,998.0000
9,998.0000
9,066.0000
8,885.0000
9,417.0000
Operating Income
-1,593.0000
-1,593.0000
-4,335.0000
-3,252.0000
-4,504.0000
Net Non Operating Interest Income Expense
62.0000
62.0000
-6.0000
-31.0000
-99.0000
Other Income Expense
-44.0000
-44.0000
64.0000
499.0000
77.0000
Pretax Income
-1,575.0000
-1,575.0000
-4,277.0000
-2,784.0000
-4,526.0000
Net Income Common Stockholders
-1,575.0000
-1,575.0000
-7,382.0000
-4,107.0000
-4,766.0000
Diluted NI Available to Com Stockholders
-1,575.0000
-1,575.0000
-7,382.0000
-4,107.0000
-4,766.0000
Basic EPS
-0.15
-0.15
-0.70
-0.41
-0.52
Diluted EPS
-0.15
-0.15
-0.70
-0.41
-0.52
Basic Average Shares
10,386.0180
10,386.0180
10,297.1340
10,017.8300
9,078.5490
Diluted Average Shares
10,386.0180
10,386.0180
10,297.1340
10,017.8300
9,078.5490
Total Operating Income as Reported
-1,593.0000
-1,593.0000
-4,335.0000
-3,252.0000
-4,275.0000
Total Expenses
15,831.0000
15,831.0000
14,310.0000
13,469.0000
13,065.0000
Net Income from Continuing & Discontinued Operation
-1,575.0000
-1,575.0000
-7,382.0000
-4,107.0000
-4,766.0000
Normalized Income
-1,575.0000
-1,575.0000
-4,553.0000
-3,506.0000
-4,995.0000
Interest Income
64.0000
64.0000
14.0000
10.0000
11.0000
Interest Expense
2.0000
2.0000
20.0000
41.0000
110.0000
Net Interest Income
62.0000
62.0000
-6.0000
-31.0000
-99.0000
EBIT
-1,573.0000
-1,573.0000
-4,257.0000
-2,743.0000
-4,416.0000
EBITDA
-1,359.0000
-1,359.0000
-3,906.0000
-2,491.0000
-4,208.0000
Reconciled Cost of Revenue
5,833.0000
5,833.0000
5,111.0000
4,524.0000
3,632.0000
Reconciled Depreciation
214.0000
214.0000
351.0000
252.0000
208.0000
Net Income from Continuing Operation Net Minority Interest
-1,575.0000
-1,575.0000
-4,553.0000
-3,024.0000
-4,766.0000
Total Unusual Items Excluding Goodwill
--
--
--
482.0000
229.0000
Total Unusual Items
--
--
--
482.0000
229.0000
Normalized EBITDA
-1,359.0000
-1,359.0000
-3,906.0000
-2,973.0000
-4,437.0000
12/31/2020 - 9/21/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NXGL NEXGEL, Inc.
2.2800
-2.15%
 
KRMD KORU Medical Systems, Inc.
2.1700
-0.90%
 
PDEX Pro-Dex, Inc.
18.20
-1.41%
 
MHUA Meihua International Medical Technologies Co., Ltd.
0.6740
-2.90%
 
INFU InfuSystem Holdings, Inc.
8.00
+5.12%
 
HBIO Harvard Bioscience, Inc.
3.6300
+1.97%
 
OSUR OraSure Technologies, Inc.
5.35
+1.69%
 
ANGO AngioDynamics, Inc.
5.82
+0.69%
 
MBOT Microbot Medical Inc.
0.8701
-0.81%
 
EMBC Embecta Corp.
10.35
-0.48%